Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 7;10(3):487.
doi: 10.3390/healthcare10030487.

Antioxidant and Anti-Inflammatory Effects of Coenzyme Q10 Supplementation on Infectious Diseases

Affiliations
Review

Antioxidant and Anti-Inflammatory Effects of Coenzyme Q10 Supplementation on Infectious Diseases

Sonia Sifuentes-Franco et al. Healthcare (Basel). .

Abstract

With the appearance of new viruses and infectious diseases (ID) such as COVID-19 in 2019, as well as the lack of specific pharmacological tools for the management of patients with severe complications or comorbidities, it is important to search for adjuvant treatments that help improve the prognosis of infectious disease patients. It is also important that these treatments limit the oxidative and hyperinflammatory damage caused as a response to pathogenic agents, since, in some cases, an inflammatory syndrome may develop that worsens the patient's prognosis. The potential benefits of complementary nutrients and dietary interventions in the treatment of pathological processes in which oxidative stress and inflammation play a fundamental role have been widely evaluated. Coenzyme Q10 (CoQ10) is a supplement that has been shown to protect cells and be effective in cardiovascular diseases and obesity. Additionally, some studies have proposed it as a possible adjuvant treatment in viral infections. Preclinical and clinical studies have shown that CoQ10 has anti-inflammatory and antioxidant effects, and effects on mitochondrial dysfunction, which have been linked to the inflammatory response.

Keywords: CoQ10; antioxidant; infectious disease; inflammation and immunomodulator; ubiquinone.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Antioxidant and anti-inflammatory functions of CoQ10. During an infectious process, the cells of the immune response produce cytokines and reactive oxygen species (ROS) as a mechanism to combat a pathogen, these ROS can produce lipoperoxidation, which can be inhibited by the direct antioxidant effect of CoQ10. The main function of CoQ10 in the mitochondria is to transfer electrons to complex III (CIII). By transferring two electrons to Complex III, the reduced form of CoQ10 (ubiquinol) is oxidized to ubiquinone. The ubiquinol pool can be restored by accepting electrons from members of the electron transport chain (CI and CII). The anti-inflammatory effects of CoQ10 may be linked to the regulation of IL-1, IL-6, CRP and TNF-α gene expression through the NF-kB pathway. Figure was created with BioRender software, (Toronto, ON, Canada) ©biorender.com.

Similar articles

Cited by

References

    1. Quinzii C.M., Lopez L.C., Von-Moltke J., Naini A., Krishna S., Schuelke M., Salviati L., Navas P., DiMauro S., Hirano M. Respiratory chain dysfunction and oxidative stress correlate with severity of primary COQ10 deficiency. FASEB J. 2008;22:1874–1885. doi: 10.1096/fj.07-100149. - DOI - PMC - PubMed
    1. Sharma A., Fonarow G.C., Butler J., Ezekowitz J.A., Felker G.M. Coenzyme Q10 and heart failure: A state-of-the-art review. Circ. Heart Fail. 2016;9:e002639. doi: 10.1161/CIRCHEARTFAILURE.115.002639. - DOI - PubMed
    1. Gutierrez-Mariscal F.M., Arenas-de Larriva A.P., Limia-Perez L., Romero-Cabrera J.L., Yubero-Serrano E.M., López-Miranda J. Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. Int. J. Mol. Sci. 2020;21:7870. doi: 10.3390/ijms21217870. - DOI - PMC - PubMed
    1. Yusuf S., Hawken S., Ôunpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364:937–952. doi: 10.1016/S0140-6736(04)17018-9. - DOI - PubMed
    1. Ellwanger J.H., Kaminski V.L., Chies J. Emerging infectious disease prevention: Where should we invest our resources and efforts? J. Infect. Public Health. 2019;12:313–316. doi: 10.1016/j.jiph.2019.03.010. - DOI - PubMed

LinkOut - more resources